

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular anion homeostasis (GO:0030002) | 6.79591275 |
| 2 | DNA deamination (GO:0045006) | 6.31884181 |
| 3 | ribosomal small subunit assembly (GO:0000028) | 6.20786194 |
| 4 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.31801694 |
| 5 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 5.31145937 |
| 6 | sleep (GO:0030431) | 5.12212603 |
| 7 | heart field specification (GO:0003128) | 5.09025696 |
| 8 | secondary heart field specification (GO:0003139) | 5.09025696 |
| 9 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 4.84931992 |
| 10 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 4.83430724 |
| 11 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 4.76300400 |
| 12 | positive regulation of cell fate commitment (GO:0010455) | 4.32218695 |
| 13 | ATP synthesis coupled proton transport (GO:0015986) | 4.26832651 |
| 14 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.26832651 |
| 15 | viral transcription (GO:0019083) | 4.25957305 |
| 16 | platelet dense granule organization (GO:0060155) | 4.23271129 |
| 17 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.14407452 |
| 18 | regulation of hypersensitivity (GO:0002883) | 4.11399531 |
| 19 | T-helper 1 type immune response (GO:0042088) | 4.02211453 |
| 20 | positive regulation of interleukin-17 production (GO:0032740) | 4.01769446 |
| 21 | regulation of protein glycosylation (GO:0060049) | 3.99538016 |
| 22 | L-fucose catabolic process (GO:0042355) | 3.96545381 |
| 23 | fucose catabolic process (GO:0019317) | 3.96545381 |
| 24 | L-fucose metabolic process (GO:0042354) | 3.96545381 |
| 25 | translational termination (GO:0006415) | 3.93302382 |
| 26 | chaperone-mediated protein transport (GO:0072321) | 3.92699726 |
| 27 | negative regulation of mast cell activation (GO:0033004) | 3.90735871 |
| 28 | cytidine metabolic process (GO:0046087) | 3.86006782 |
| 29 | cytidine catabolic process (GO:0006216) | 3.86006782 |
| 30 | cytidine deamination (GO:0009972) | 3.86006782 |
| 31 | behavioral response to nicotine (GO:0035095) | 3.84095866 |
| 32 | necroptotic process (GO:0070266) | 3.82326757 |
| 33 | growth hormone receptor signaling pathway (GO:0060396) | 3.75557036 |
| 34 | negative regulation of cell fate specification (GO:0009996) | 3.75279577 |
| 35 | cardiac ventricle formation (GO:0003211) | 3.67164207 |
| 36 | regulation of mesoderm development (GO:2000380) | 3.62643312 |
| 37 | cell migration involved in heart development (GO:0060973) | 3.60055832 |
| 38 | T cell apoptotic process (GO:0070231) | 3.58184230 |
| 39 | intracellular pH reduction (GO:0051452) | 3.58081271 |
| 40 | ribosomal large subunit biogenesis (GO:0042273) | 3.54390333 |
| 41 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 3.52797563 |
| 42 | regulation of metalloenzyme activity (GO:0048552) | 3.52724747 |
| 43 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.42059837 |
| 44 | positive regulation of ERBB signaling pathway (GO:1901186) | 3.40961631 |
| 45 | cellular response to growth hormone stimulus (GO:0071378) | 3.40711211 |
| 46 | maturation of SSU-rRNA (GO:0030490) | 3.40078173 |
| 47 | cardiac chamber formation (GO:0003207) | 3.37126683 |
| 48 | positive regulation of prostaglandin secretion (GO:0032308) | 3.36048998 |
| 49 | translational elongation (GO:0006414) | 3.35267428 |
| 50 | cotranslational protein targeting to membrane (GO:0006613) | 3.33887728 |
| 51 | GPI anchor biosynthetic process (GO:0006506) | 3.33458242 |
| 52 | immunoglobulin mediated immune response (GO:0016064) | 3.33235564 |
| 53 | specification of organ identity (GO:0010092) | 3.32812882 |
| 54 | protein targeting to ER (GO:0045047) | 3.31655774 |
| 55 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.22971306 |
| 56 | transcription from RNA polymerase I promoter (GO:0006360) | 3.22332431 |
| 57 | protein localization to endoplasmic reticulum (GO:0070972) | 3.19804927 |
| 58 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.19551380 |
| 59 | GPI anchor metabolic process (GO:0006505) | 3.15004388 |
| 60 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.14794073 |
| 61 | termination of RNA polymerase III transcription (GO:0006386) | 3.14794073 |
| 62 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.13296167 |
| 63 | NADH dehydrogenase complex assembly (GO:0010257) | 3.13296167 |
| 64 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.13296167 |
| 65 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.09436499 |
| 66 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.08870384 |
| 67 | programmed necrotic cell death (GO:0097300) | 3.04340783 |
| 68 | ncRNA 3-end processing (GO:0043628) | 3.04119426 |
| 69 | regulation of interleukin-8 secretion (GO:2000482) | 3.03673843 |
| 70 | ribosomal small subunit biogenesis (GO:0042274) | 3.03650806 |
| 71 | positive regulation of fibroblast migration (GO:0010763) | 3.02211676 |
| 72 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.01504579 |
| 73 | lymphocyte apoptotic process (GO:0070227) | 3.00512945 |
| 74 | activated T cell proliferation (GO:0050798) | 3.00395125 |
| 75 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.93884104 |
| 76 | pH reduction (GO:0045851) | 2.91142328 |
| 77 | negative regulation of cell fate commitment (GO:0010454) | 2.90724919 |
| 78 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.90281927 |
| 79 | cell wall macromolecule metabolic process (GO:0044036) | 2.90046608 |
| 80 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.89739953 |
| 81 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.89342259 |
| 82 | respiratory electron transport chain (GO:0022904) | 2.89312265 |
| 83 | viral life cycle (GO:0019058) | 2.88366526 |
| 84 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.87190391 |
| 85 | electron transport chain (GO:0022900) | 2.86304201 |
| 86 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.85982599 |
| 87 | cytokine biosynthetic process (GO:0042089) | 2.84577425 |
| 88 | positive regulation of defense response to virus by host (GO:0002230) | 2.83400673 |
| 89 | B cell mediated immunity (GO:0019724) | 2.82540421 |
| 90 | cell wall macromolecule catabolic process (GO:0016998) | 2.82318376 |
| 91 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 2.79191065 |
| 92 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.77252973 |
| 93 | positive regulation of mast cell degranulation (GO:0043306) | 2.77252973 |
| 94 | cellular protein complex disassembly (GO:0043624) | 2.76226109 |
| 95 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.76135483 |
| 96 | positive regulation of mast cell activation (GO:0033005) | 2.76134205 |
| 97 | protein complex biogenesis (GO:0070271) | 2.75342533 |
| 98 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.74358986 |
| 99 | positive regulation of protein homodimerization activity (GO:0090073) | 2.74131126 |
| 100 | ATP biosynthetic process (GO:0006754) | 2.72545459 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.55271826 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.44706684 |
| 3 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 3.12834202 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.07594809 |
| 5 | VDR_22108803_ChIP-Seq_LS180_Human | 3.07181020 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.99440950 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.97814514 |
| 8 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.61452256 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.56954486 |
| 10 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.50607100 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.42159197 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.21898522 |
| 13 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.17747705 |
| 14 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.15117691 |
| 15 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.14685961 |
| 16 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.12564666 |
| 17 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.06739908 |
| 18 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 2.02671526 |
| 19 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.96228828 |
| 20 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.84742194 |
| 21 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.80680247 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.79286102 |
| 23 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.79156595 |
| 24 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.77131520 |
| 25 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.76028481 |
| 26 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.73775242 |
| 27 | GATA3_26560356_Chip-Seq_TH2_Human | 1.72527441 |
| 28 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.62854416 |
| 29 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.56158160 |
| 30 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.55965872 |
| 31 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.52439770 |
| 32 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.49081068 |
| 33 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.46710878 |
| 34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.46378202 |
| 35 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.44133770 |
| 36 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.42665547 |
| 37 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.41928013 |
| 38 | AR_20517297_ChIP-Seq_VCAP_Human | 1.37805143 |
| 39 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.37035316 |
| 40 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.35593892 |
| 41 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.35181883 |
| 42 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.34463660 |
| 43 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.34087028 |
| 44 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31705215 |
| 45 | FUS_26573619_Chip-Seq_HEK293_Human | 1.31621644 |
| 46 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.31376040 |
| 47 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.29465541 |
| 48 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.29465541 |
| 49 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.29210413 |
| 50 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.28638447 |
| 51 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.28638447 |
| 52 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.27508717 |
| 53 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.27203735 |
| 54 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.24715832 |
| 55 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.22667709 |
| 56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.22431415 |
| 57 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.22207012 |
| 58 | EWS_26573619_Chip-Seq_HEK293_Human | 1.20441615 |
| 59 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.20329411 |
| 60 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.20072504 |
| 61 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.19645287 |
| 62 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.19302898 |
| 63 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.19059182 |
| 64 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.18872740 |
| 65 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.17759732 |
| 66 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.17109966 |
| 67 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.14266014 |
| 68 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.13340988 |
| 69 | ERA_21632823_ChIP-Seq_H3396_Human | 1.12141908 |
| 70 | GATA3_26560356_Chip-Seq_TH1_Human | 1.12023813 |
| 71 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.11251178 |
| 72 | P300_19829295_ChIP-Seq_ESCs_Human | 1.10498527 |
| 73 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.09405216 |
| 74 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.08372442 |
| 75 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.07329810 |
| 76 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.02411288 |
| 77 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.02312226 |
| 78 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02075405 |
| 79 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.01507643 |
| 80 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.01433180 |
| 81 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.01039807 |
| 82 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.00057271 |
| 83 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99808997 |
| 84 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.99478262 |
| 85 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.97391863 |
| 86 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.96143248 |
| 87 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.95598167 |
| 88 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.95218321 |
| 89 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.94910428 |
| 90 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.94645589 |
| 91 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94486220 |
| 92 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.94034054 |
| 93 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.93787146 |
| 94 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92636213 |
| 95 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.91737108 |
| 96 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.90457851 |
| 97 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.90296801 |
| 98 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.90088902 |
| 99 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.89342220 |
| 100 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.89218105 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002234_abnormal_pharynx_morphology | 4.97042894 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.49118986 |
| 3 | MP0001873_stomach_inflammation | 3.30905580 |
| 4 | MP0005671_abnormal_response_to | 2.90514958 |
| 5 | MP0006082_CNS_inflammation | 2.77769291 |
| 6 | MP0005646_abnormal_pituitary_gland | 2.75911344 |
| 7 | MP0009379_abnormal_foot_pigmentation | 2.68813241 |
| 8 | MP0006292_abnormal_olfactory_placode | 2.60676016 |
| 9 | MP0001529_abnormal_vocalization | 2.59823509 |
| 10 | MP0003724_increased_susceptibility_to | 2.59312421 |
| 11 | MP0003646_muscle_fatigue | 2.47649215 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.42116289 |
| 13 | MP0004147_increased_porphyrin_level | 2.40408968 |
| 14 | MP0006072_abnormal_retinal_apoptosis | 2.27885138 |
| 15 | MP0008872_abnormal_physiological_respon | 2.09614166 |
| 16 | MP0000465_gastrointestinal_hemorrhage | 1.99730890 |
| 17 | MP0001905_abnormal_dopamine_level | 1.97805605 |
| 18 | MP0001800_abnormal_humoral_immune | 1.96713740 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 1.94243974 |
| 20 | MP0005253_abnormal_eye_physiology | 1.93150081 |
| 21 | MP0002933_joint_inflammation | 1.88663983 |
| 22 | MP0004142_abnormal_muscle_tone | 1.86084651 |
| 23 | MP0005000_abnormal_immune_tolerance | 1.73442360 |
| 24 | MP0003011_delayed_dark_adaptation | 1.64414595 |
| 25 | MP0002452_abnormal_antigen_presenting | 1.58974912 |
| 26 | MP0002876_abnormal_thyroid_physiology | 1.56375117 |
| 27 | MP0002723_abnormal_immune_serum | 1.55575583 |
| 28 | MP0002822_catalepsy | 1.54963610 |
| 29 | MP0001986_abnormal_taste_sensitivity | 1.46432616 |
| 30 | MP0000569_abnormal_digit_pigmentation | 1.46341352 |
| 31 | MP0005551_abnormal_eye_electrophysiolog | 1.45208790 |
| 32 | MP0000230_abnormal_systemic_arterial | 1.41219968 |
| 33 | MP0009046_muscle_twitch | 1.36252875 |
| 34 | MP0005360_urolithiasis | 1.28814120 |
| 35 | MP0005025_abnormal_response_to | 1.27490542 |
| 36 | MP0001819_abnormal_immune_cell | 1.24431512 |
| 37 | MP0002420_abnormal_adaptive_immunity | 1.23648088 |
| 38 | MP0002419_abnormal_innate_immunity | 1.21670967 |
| 39 | MP0009785_altered_susceptibility_to | 1.21508538 |
| 40 | MP0004885_abnormal_endolymph | 1.18714917 |
| 41 | MP0003195_calcinosis | 1.18227124 |
| 42 | MP0002736_abnormal_nociception_after | 1.16907547 |
| 43 | MP0000372_irregular_coat_pigmentation | 1.16469992 |
| 44 | MP0008995_early_reproductive_senescence | 1.13821979 |
| 45 | MP0000685_abnormal_immune_system | 1.12825708 |
| 46 | MP0001968_abnormal_touch/_nociception | 1.11794326 |
| 47 | MP0008775_abnormal_heart_ventricle | 1.08477468 |
| 48 | MP0008469_abnormal_protein_level | 1.08448992 |
| 49 | MP0001790_abnormal_immune_system | 1.07831028 |
| 50 | MP0005387_immune_system_phenotype | 1.07831028 |
| 51 | MP0001663_abnormal_digestive_system | 1.07624813 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.05771785 |
| 53 | MP0010386_abnormal_urinary_bladder | 1.05239919 |
| 54 | MP0002163_abnormal_gland_morphology | 1.03480394 |
| 55 | MP0002272_abnormal_nervous_system | 1.03014209 |
| 56 | MP0002138_abnormal_hepatobiliary_system | 1.01757058 |
| 57 | MP0001851_eye_inflammation | 0.99803162 |
| 58 | MP0001765_abnormal_ion_homeostasis | 0.98969621 |
| 59 | MP0004130_abnormal_muscle_cell | 0.95663513 |
| 60 | MP0005645_abnormal_hypothalamus_physiol | 0.95638983 |
| 61 | MP0009745_abnormal_behavioral_response | 0.95308316 |
| 62 | MP0006276_abnormal_autonomic_nervous | 0.94647608 |
| 63 | MP0003638_abnormal_response/metabolism_ | 0.92929672 |
| 64 | MP0003075_altered_response_to | 0.92705337 |
| 65 | MP0005367_renal/urinary_system_phenotyp | 0.92031804 |
| 66 | MP0000516_abnormal_urinary_system | 0.92031804 |
| 67 | MP0005075_abnormal_melanosome_morpholog | 0.91835847 |
| 68 | MP0008877_abnormal_DNA_methylation | 0.90530359 |
| 69 | MP0004145_abnormal_muscle_electrophysio | 0.88427223 |
| 70 | MP0008058_abnormal_DNA_repair | 0.86705955 |
| 71 | MP0005166_decreased_susceptibility_to | 0.86002085 |
| 72 | MP0002277_abnormal_respiratory_mucosa | 0.85547148 |
| 73 | MP0001440_abnormal_grooming_behavior | 0.85533968 |
| 74 | MP0006036_abnormal_mitochondrial_physio | 0.84725185 |
| 75 | MP0009764_decreased_sensitivity_to | 0.82662687 |
| 76 | MP0002837_dystrophic_cardiac_calcinosis | 0.81806308 |
| 77 | MP0000716_abnormal_immune_system | 0.81108259 |
| 78 | MP0005636_abnormal_mineral_homeostasis | 0.80155134 |
| 79 | MP0005195_abnormal_posterior_eye | 0.80118452 |
| 80 | MP0003950_abnormal_plasma_membrane | 0.79382849 |
| 81 | MP0010155_abnormal_intestine_physiology | 0.78477425 |
| 82 | MP0003436_decreased_susceptibility_to | 0.78252843 |
| 83 | MP0004924_abnormal_behavior | 0.78047588 |
| 84 | MP0005386_behavior/neurological_phenoty | 0.78047588 |
| 85 | MP0000013_abnormal_adipose_tissue | 0.77693456 |
| 86 | MP0005084_abnormal_gallbladder_morpholo | 0.76381296 |
| 87 | MP0003787_abnormal_imprinting | 0.75740931 |
| 88 | MP0008873_increased_physiological_sensi | 0.75666743 |
| 89 | MP0001970_abnormal_pain_threshold | 0.74166065 |
| 90 | MP0005595_abnormal_vascular_smooth | 0.74114243 |
| 91 | MP0002572_abnormal_emotion/affect_behav | 0.74098677 |
| 92 | MP0005389_reproductive_system_phenotype | 0.73533299 |
| 93 | MP0005381_digestive/alimentary_phenotyp | 0.73320700 |
| 94 | MP0009333_abnormal_splenocyte_physiolog | 0.73064962 |
| 95 | MP0002095_abnormal_skin_pigmentation | 0.72823977 |
| 96 | MP0003866_abnormal_defecation | 0.71123984 |
| 97 | MP0001486_abnormal_startle_reflex | 0.70952383 |
| 98 | MP0005085_abnormal_gallbladder_physiolo | 0.70071040 |
| 99 | MP0001664_abnormal_digestion | 0.68814288 |
| 100 | MP0005391_vision/eye_phenotype | 0.66047590 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Autoimmune thrombocytopenia (HP:0001973) | 7.36027219 |
| 2 | Autoimmune hemolytic anemia (HP:0001890) | 6.17339159 |
| 3 | Increased IgM level (HP:0003496) | 5.93515014 |
| 4 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 5.73235203 |
| 5 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.48182221 |
| 6 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.48182221 |
| 7 | Eosinophilia (HP:0001880) | 4.33598217 |
| 8 | Hypochromic anemia (HP:0001931) | 3.84118320 |
| 9 | Abnormality of T cell number (HP:0011839) | 3.83992729 |
| 10 | Birth length less than 3rd percentile (HP:0003561) | 3.77990776 |
| 11 | Anterior segment dysgenesis (HP:0007700) | 3.60618593 |
| 12 | Type II lissencephaly (HP:0007260) | 3.60116149 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.56655437 |
| 14 | Acute necrotizing encephalopathy (HP:0006965) | 3.42553814 |
| 15 | Abnormality of eosinophils (HP:0001879) | 3.40362284 |
| 16 | Enlarged epiphyses (HP:0010580) | 3.39601038 |
| 17 | Granulocytopenia (HP:0001913) | 3.37604627 |
| 18 | Myotonia (HP:0002486) | 3.30645252 |
| 19 | Leukocytosis (HP:0001974) | 3.27609071 |
| 20 | Lip pit (HP:0100267) | 3.14971908 |
| 21 | Cerebellar dysplasia (HP:0007033) | 3.10342744 |
| 22 | Agammaglobulinemia (HP:0004432) | 3.09095971 |
| 23 | Abnormality of T cell physiology (HP:0011840) | 3.08067451 |
| 24 | Congenital stationary night blindness (HP:0007642) | 3.02933124 |
| 25 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.98980772 |
| 26 | Progressive macrocephaly (HP:0004481) | 2.97618302 |
| 27 | Congenital, generalized hypertrichosis (HP:0004540) | 2.96793846 |
| 28 | Hepatocellular necrosis (HP:0001404) | 2.88928620 |
| 29 | Acute encephalopathy (HP:0006846) | 2.86680873 |
| 30 | Mitochondrial inheritance (HP:0001427) | 2.86623672 |
| 31 | Neonatal hypoglycemia (HP:0001998) | 2.76696899 |
| 32 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.64657818 |
| 33 | Type 2 muscle fiber atrophy (HP:0003554) | 2.63727441 |
| 34 | Vasculitis (HP:0002633) | 2.59355146 |
| 35 | Increased CSF lactate (HP:0002490) | 2.58515967 |
| 36 | Glucose intolerance (HP:0000833) | 2.49331325 |
| 37 | Hepatic necrosis (HP:0002605) | 2.43667787 |
| 38 | Abolished electroretinogram (ERG) (HP:0000550) | 2.43229675 |
| 39 | Attenuation of retinal blood vessels (HP:0007843) | 2.40112184 |
| 40 | Depressed nasal tip (HP:0000437) | 2.36536892 |
| 41 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.34896222 |
| 42 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.33113019 |
| 43 | Chin dimple (HP:0010751) | 2.30287675 |
| 44 | Muscle fiber atrophy (HP:0100295) | 2.30279486 |
| 45 | Abnormality of T cells (HP:0002843) | 2.28614062 |
| 46 | IgG deficiency (HP:0004315) | 2.28371343 |
| 47 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.24347416 |
| 48 | Pancreatic cysts (HP:0001737) | 2.24233973 |
| 49 | Hypergammaglobulinemia (HP:0010702) | 2.23179027 |
| 50 | 3-Methylglutaconic aciduria (HP:0003535) | 2.18848315 |
| 51 | Hypothermia (HP:0002045) | 2.18338292 |
| 52 | Reticulocytopenia (HP:0001896) | 2.14601587 |
| 53 | Molar tooth sign on MRI (HP:0002419) | 2.14303297 |
| 54 | Abnormality of midbrain morphology (HP:0002418) | 2.14303297 |
| 55 | Urticaria (HP:0001025) | 2.11394930 |
| 56 | Hypoproteinemia (HP:0003075) | 2.09635021 |
| 57 | Periodontitis (HP:0000704) | 2.09312403 |
| 58 | Recurrent abscess formation (HP:0002722) | 2.07193252 |
| 59 | Methylmalonic acidemia (HP:0002912) | 2.07103297 |
| 60 | Cerebral edema (HP:0002181) | 2.06286064 |
| 61 | Abnormality of the prostate (HP:0008775) | 2.04438861 |
| 62 | Neutropenia (HP:0001875) | 2.03945173 |
| 63 | Chronic bronchitis (HP:0004469) | 2.02345528 |
| 64 | Lipid accumulation in hepatocytes (HP:0006561) | 2.01699540 |
| 65 | Decreased central vision (HP:0007663) | 2.00555659 |
| 66 | Increased hepatocellular lipid droplets (HP:0006565) | 1.99392938 |
| 67 | Hyperglycemia (HP:0003074) | 1.97724361 |
| 68 | Sparse lateral eyebrow (HP:0005338) | 1.96915392 |
| 69 | Abnormality of the columella (HP:0009929) | 1.96515007 |
| 70 | Cerebral palsy (HP:0100021) | 1.96421211 |
| 71 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.95883904 |
| 72 | Nephronophthisis (HP:0000090) | 1.94931396 |
| 73 | Meningitis (HP:0001287) | 1.93308841 |
| 74 | Respiratory failure (HP:0002878) | 1.92676914 |
| 75 | Optic disc pallor (HP:0000543) | 1.91514458 |
| 76 | Abnormal glucose tolerance (HP:0001952) | 1.90590496 |
| 77 | Stomatitis (HP:0010280) | 1.89765851 |
| 78 | Alveolar cell carcinoma (HP:0006519) | 1.89274400 |
| 79 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.88892400 |
| 80 | Fatigable weakness (HP:0003473) | 1.88233404 |
| 81 | Abnormality of the neuromuscular junction (HP:0003398) | 1.88233404 |
| 82 | Constricted visual fields (HP:0001133) | 1.87936698 |
| 83 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.87541831 |
| 84 | True hermaphroditism (HP:0010459) | 1.87109210 |
| 85 | Pancreatic fibrosis (HP:0100732) | 1.84678074 |
| 86 | B lymphocytopenia (HP:0010976) | 1.83425546 |
| 87 | Hyperglycinemia (HP:0002154) | 1.82634539 |
| 88 | Epileptic encephalopathy (HP:0200134) | 1.81894787 |
| 89 | Hypomagnesemia (HP:0002917) | 1.80481006 |
| 90 | Lethargy (HP:0001254) | 1.80019121 |
| 91 | Pendular nystagmus (HP:0012043) | 1.79479305 |
| 92 | Abnormality of B cell number (HP:0010975) | 1.79184774 |
| 93 | Abnormality of magnesium homeostasis (HP:0004921) | 1.75839593 |
| 94 | Ectropion (HP:0000656) | 1.75616305 |
| 95 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.75335338 |
| 96 | Abnormality of macular pigmentation (HP:0008002) | 1.74079077 |
| 97 | Abnormal number of erythroid precursors (HP:0012131) | 1.73325759 |
| 98 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.73160517 |
| 99 | Increased corneal curvature (HP:0100692) | 1.72179400 |
| 100 | Keratoconus (HP:0000563) | 1.72179400 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TLK1 | 8.18073014 |
| 2 | PIK3CA | 4.60876940 |
| 3 | CDK19 | 4.07975652 |
| 4 | MAP4K2 | 3.75195774 |
| 5 | TAOK3 | 3.23383095 |
| 6 | BMPR2 | 2.97132360 |
| 7 | KIT | 2.16024468 |
| 8 | TXK | 2.13588960 |
| 9 | GRK1 | 1.94764765 |
| 10 | CAMKK2 | 1.92767031 |
| 11 | FES | 1.87776128 |
| 12 | FRK | 1.77378031 |
| 13 | PRKCH | 1.69855859 |
| 14 | ADRBK2 | 1.64417754 |
| 15 | MAP4K1 | 1.60884384 |
| 16 | OXSR1 | 1.58405855 |
| 17 | ZAK | 1.44863426 |
| 18 | MAP2K6 | 1.35062876 |
| 19 | GRK6 | 1.17431293 |
| 20 | PBK | 1.11783979 |
| 21 | MAP3K6 | 1.09577713 |
| 22 | TIE1 | 1.09065939 |
| 23 | SYK | 1.08703924 |
| 24 | CAMK1D | 1.07131912 |
| 25 | ERBB3 | 1.06729840 |
| 26 | LCK | 1.02158117 |
| 27 | IKBKB | 1.01374727 |
| 28 | MAPK12 | 1.00516159 |
| 29 | PINK1 | 1.00354568 |
| 30 | GRK7 | 0.99498988 |
| 31 | PRKCG | 0.98628784 |
| 32 | DAPK1 | 0.98422816 |
| 33 | ADRBK1 | 0.95289005 |
| 34 | MATK | 0.86954867 |
| 35 | WNK4 | 0.84339361 |
| 36 | INSRR | 0.84326587 |
| 37 | RIPK4 | 0.84039338 |
| 38 | NUAK1 | 0.81482623 |
| 39 | TEC | 0.78592476 |
| 40 | MAP3K12 | 0.77937265 |
| 41 | STK16 | 0.77667396 |
| 42 | CSF1R | 0.77129584 |
| 43 | LYN | 0.76879722 |
| 44 | RET | 0.76673157 |
| 45 | MINK1 | 0.73045163 |
| 46 | PHKG1 | 0.72502417 |
| 47 | PHKG2 | 0.72502417 |
| 48 | BCKDK | 0.71029361 |
| 49 | ILK | 0.70553259 |
| 50 | PRKCQ | 0.68964904 |
| 51 | JAK3 | 0.67968785 |
| 52 | TRPM7 | 0.67966400 |
| 53 | PKN1 | 0.66274758 |
| 54 | MAP2K3 | 0.65251048 |
| 55 | MYLK | 0.63901924 |
| 56 | TYRO3 | 0.63087721 |
| 57 | GRK5 | 0.62414627 |
| 58 | PIK3CG | 0.60178282 |
| 59 | CAMKK1 | 0.58047905 |
| 60 | IGF1R | 0.57058607 |
| 61 | FLT3 | 0.54441990 |
| 62 | ITK | 0.54384128 |
| 63 | ZAP70 | 0.53647971 |
| 64 | BTK | 0.53518692 |
| 65 | NME1 | 0.51475500 |
| 66 | DAPK2 | 0.48529250 |
| 67 | MAPK13 | 0.47578983 |
| 68 | OBSCN | 0.47147148 |
| 69 | WNK3 | 0.46041008 |
| 70 | PRKCD | 0.45096168 |
| 71 | SCYL2 | 0.44386968 |
| 72 | CAMK1 | 0.44265180 |
| 73 | MARK3 | 0.43944469 |
| 74 | PRKACA | 0.43257381 |
| 75 | CAMK2A | 0.43160951 |
| 76 | MAP2K2 | 0.43075110 |
| 77 | PDGFRB | 0.42879109 |
| 78 | STK11 | 0.41933660 |
| 79 | RPS6KA5 | 0.41652024 |
| 80 | KDR | 0.39990152 |
| 81 | MOS | 0.39933959 |
| 82 | PLK4 | 0.39497221 |
| 83 | PRKCA | 0.38490831 |
| 84 | CSK | 0.37644147 |
| 85 | MAP2K4 | 0.37284427 |
| 86 | PRKG1 | 0.37151568 |
| 87 | ABL1 | 0.36010870 |
| 88 | MAPK15 | 0.34776512 |
| 89 | DAPK3 | 0.33824955 |
| 90 | ERBB2 | 0.33613350 |
| 91 | CSNK1G3 | 0.31339512 |
| 92 | TNK2 | 0.30641880 |
| 93 | CSNK2A2 | 0.28784568 |
| 94 | MAPKAPK5 | 0.27817665 |
| 95 | HCK | 0.27411933 |
| 96 | NME2 | 0.26272929 |
| 97 | MKNK1 | 0.24855470 |
| 98 | CSNK1G1 | 0.24797820 |
| 99 | PRKCB | 0.24524606 |
| 100 | PRKACG | 0.23394595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 4.78339717 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.62186997 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.54476113 |
| 4 | Asthma_Homo sapiens_hsa05310 | 4.17703277 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 4.07408928 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.08916551 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.97060588 |
| 8 | Ribosome_Homo sapiens_hsa03010 | 2.70740031 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.34970467 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.23566575 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.23290410 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.10116914 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 2.06974203 |
| 14 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.03941739 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.97915922 |
| 16 | Parkinsons disease_Homo sapiens_hsa05012 | 1.97299920 |
| 17 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.96142009 |
| 18 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.85338171 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.64690820 |
| 20 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.56978342 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.50545880 |
| 22 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.50026942 |
| 23 | Phototransduction_Homo sapiens_hsa04744 | 1.43746960 |
| 24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.41300906 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.39193653 |
| 26 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.32144462 |
| 27 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.21986293 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.14964708 |
| 29 | Alzheimers disease_Homo sapiens_hsa05010 | 1.13412681 |
| 30 | Homologous recombination_Homo sapiens_hsa03440 | 1.10728845 |
| 31 | Proteasome_Homo sapiens_hsa03050 | 1.09273926 |
| 32 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.08295893 |
| 33 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.07265538 |
| 34 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.05582610 |
| 35 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.00256032 |
| 36 | Huntingtons disease_Homo sapiens_hsa05016 | 0.99761856 |
| 37 | Legionellosis_Homo sapiens_hsa05134 | 0.99088212 |
| 38 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.90023416 |
| 39 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.83245919 |
| 40 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.77817424 |
| 41 | Olfactory transduction_Homo sapiens_hsa04740 | 0.75763022 |
| 42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.73047998 |
| 43 | Purine metabolism_Homo sapiens_hsa00230 | 0.72531371 |
| 44 | Protein export_Homo sapiens_hsa03060 | 0.72359651 |
| 45 | Pertussis_Homo sapiens_hsa05133 | 0.70765372 |
| 46 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.67596271 |
| 47 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.66376049 |
| 48 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.63774707 |
| 49 | Influenza A_Homo sapiens_hsa05164 | 0.60807939 |
| 50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60454099 |
| 51 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.60225696 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.58692610 |
| 53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.58505362 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.57247162 |
| 55 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.55732620 |
| 56 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.55311033 |
| 57 | Tuberculosis_Homo sapiens_hsa05152 | 0.54685924 |
| 58 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.53358953 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51817217 |
| 60 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.51627908 |
| 61 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.48937935 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.46493850 |
| 63 | Measles_Homo sapiens_hsa05162 | 0.45301043 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43189310 |
| 65 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.40737832 |
| 66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39778985 |
| 67 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38384041 |
| 68 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.35614775 |
| 69 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.35349660 |
| 70 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.32550582 |
| 71 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.31475944 |
| 72 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.31287025 |
| 73 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.30959976 |
| 74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.30435707 |
| 75 | Salivary secretion_Homo sapiens_hsa04970 | 0.30395916 |
| 76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29338644 |
| 77 | Basal transcription factors_Homo sapiens_hsa03022 | 0.28263590 |
| 78 | RNA degradation_Homo sapiens_hsa03018 | 0.27945233 |
| 79 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.24036283 |
| 80 | Nicotine addiction_Homo sapiens_hsa05033 | 0.23884638 |
| 81 | RNA transport_Homo sapiens_hsa03013 | 0.23341105 |
| 82 | Taste transduction_Homo sapiens_hsa04742 | 0.23193379 |
| 83 | Phagosome_Homo sapiens_hsa04145 | 0.22987568 |
| 84 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.21927821 |
| 85 | Spliceosome_Homo sapiens_hsa03040 | 0.20922241 |
| 86 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.20894579 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.20780776 |
| 88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.20069038 |
| 89 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.19248702 |
| 90 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.18737396 |
| 91 | Mismatch repair_Homo sapiens_hsa03430 | 0.18640412 |
| 92 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.18016680 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17065346 |
| 94 | Peroxisome_Homo sapiens_hsa04146 | 0.15932935 |
| 95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.15800580 |
| 96 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.12380361 |
| 97 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.12055081 |
| 98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.10897974 |
| 99 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.10654410 |
| 100 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.10429455 |

